For following the competition: what moved in each program, several studies read as one move.
- CLR1404
- zanubrutinib
- rocbrutinib
- + 8 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Waldenstrom Macroglobulinemia to watchlistEvery Monday by email · turn it off any timePro · free during the beta